Curapatient, INC.

AI health care technology driven platform company helping patients more easily access care

Based in CA

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $10K in lobbying spend across 5 quarterly filings, Curapatient, INC is an active lobbying client. Their lobbying covers 2 issue areas.

$10K
Total Spend
1
Years Active
1
Firms Hired
1
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2024$10K

Issues Lobbied

Budget/AppropriationsVeterans

Lobbying Firms

Squire Patton Boggs

Lobbyists

Adam Berg

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Veterans

  • •General outreach regarding funding / programmatic requests.
  • •H.R. 8580, the Military Construction and Veterans Affairs Appropriations Act, FY2025, title II, veterans health.
  • •House on Veterans Affairs Appropriations Act, FY2025, title II, veterans health.

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

International Myeloma Foundation
$2.6M total spend
Teladoc Health, INC.
$2.5M total spend
Health Net Federal Services
$1.7M total spend
Housing Authority of the County of San Bernardino (Hacsb)
$1.2M total spend
American Academy of Ophthalmology
$990K total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.